Prescription drug advertising, disease knowledge, and older adults' optimistic bias about the future risk of alzheimer's disease
Abstract This study aims to broaden the scope of knowledge on the role of direct to consumer prescription drug advertising (DTCA) in the construction of consumers' optimistic bias regarding health issues and their intentions for coping actions. Based on an online survey of U.S. adults aged 65 years or older (N 622) this study revealed that (a) respondents were optimistically biased in estimating their future risk of Alzheimer's disease (AD) (b) exposure to DTCA for AD medicine related negatively to optimistic bias when respondents had a low level of knowledge about AD, while the relationship disappeared when knowledge was high; (c) optimistic bias was negatively associated with intentions to seek information about AD and professional help to discuss it; and (d) optimistic bias mediated the relationship between the DTCA exposure x AD knowledge interaction and information and help seeking intentions. Implications for the theory and practice of DTCA are discussed.
Health communication